Her primary areas of investigation include Semicarbazone, Biochemistry, Stereochemistry, Chelation and Combinatorial chemistry. Her Semicarbazone research is multidisciplinary, relying on both Zinc and In vitro. Her Stereochemistry research incorporates elements of Pyridine, Structure–activity relationship, Ligand and Iron Chelating Agents.
Her research investigates the connection between Structure–activity relationship and topics such as Chemical synthesis that intersect with issues in Redox and Lipophilicity. She studied Chelation and Deferoxamine that intersect with Drug, Cancer biology and Penicillamine. The various areas that Danuta S. Kalinowski examines in her Combinatorial chemistry study include Inorganic chemistry, Biological activity and Hydrazone.
Her scientific interests lie mostly in Biochemistry, Chelation, Stereochemistry, Cancer cell and Semicarbazone. Danuta S. Kalinowski interconnects Hydrazone, Combinatorial chemistry and Cytotoxicity in the investigation of issues within Chelation. Danuta S. Kalinowski has researched Stereochemistry in several fields, including Biological activity, Redox, Structure–activity relationship and Chemical synthesis.
Her Structure–activity relationship research integrates issues from Pyridine and Medicinal chemistry. Her studies in Cancer cell integrate themes in fields like Cancer research, Apoptosis, DNA synthesis, Cell biology and Pharmacology. Her Semicarbazone study incorporates themes from In vitro, Ligand and Copper.
Her main research concerns Biochemistry, Pharmacology, Cell biology, Cancer cell and Cytotoxicity. The concepts of her Biochemistry study are interwoven with issues in Semicarbazone, Homeostasis and Copper. Her Pharmacology study combines topics in areas such as Pharmacophore, Oxidative stress and Hypertrophic cardiomyopathy.
Her Cancer cell study which covers Apoptosis that intersects with Neuroblastoma. Her Cytotoxicity study combines topics in areas such as Lead compound, Zinc and Liposome. Her Reactive oxygen species study integrates concerns from other disciplines, such as Cell growth, Mechanism of action, Chelation, Structure–activity relationship and Programmed cell death.
Danuta S. Kalinowski mostly deals with Cytotoxicity, Biochemistry, Cancer cell, Reactive oxygen species and Pharmacology. Her Biochemistry research is multidisciplinary, relying on both Carcinogenesis, Targeted drug delivery, Copper, Semicarbazone and Metastasis Suppressor Gene. Her study in Semicarbazone is interdisciplinary in nature, drawing from both In vitro, Mechanism of action, Metastasis, Metastasis Suppressor Protein and Enzyme.
Her research brings together the fields of Cell growth and Cancer cell. Her biological study spans a wide range of topics, including Autophagy, Oxidative stress, Chelation, Amyotrophic lateral sclerosis and Ataxia. Her research in Chelation intersects with topics in Lipophilicity, Structure–activity relationship and Drug discovery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Griffith University
University of Queensland
University of Copenhagen
University of New South Wales
University of Illinois at Chicago
University of Wollongong
Edith Cowan University
George Mason University
Agostino Gemelli University Polyclinic
University of South Florida